Research/P-06
P-06Muscle39 studies indexed

IGF-1 LR3

Skips the middleman. Builds muscle directly.

By HelixHouse Research TeamPublished Last reviewed
01 · Overview

IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a synthetic analog of IGF-1 modified with an arginine substitution and an extended N-terminal peptide. Those modifications reduce its binding to IGF binding proteins (IGFBPs), which extends its active half-life from about 15 minutes (native IGF-1) to closer to 20-30 hours. IGF-1 is the downstream effector of growth hormone — LR3 skips the GH-to-IGF conversion step and delivers the anabolic signal directly.

02 · Mechanism of Action

Binds IGF-1 receptors on muscle cells and drives PI3K/Akt/mTOR signaling — the primary anabolic pathway for protein synthesis. Also stimulates satellite cell proliferation and differentiation, expanding the pool of nuclei available to muscle fibers. Partial insulin-receptor cross-reactivity means it also drives glucose uptake.

03 · Current Evidence
  • E.01Widely-cited animal models show substantial muscle hypertrophy from exogenous IGF-1 administration.
  • E.02Human clinical use has been studied for cachexia, GH insensitivity syndromes, and post-surgical recovery.
  • E.03Direct performance enhancement data comes largely from animal and cell studies, not controlled human trials.
04 · Reported Benefits
B.01Rapid, visible muscle hypertrophy during growth phases
B.02Dramatically reduced recovery time between sessions
B.03Improved nutrient partitioning — food goes toward muscle, not fat
B.04Increased strength alongside size gains
05 · Safety Considerations

Advanced-user territory. Insulin-mimetic effects can cause hypoglycemia — do not use without a clear plan for food timing and glucose monitoring. Long-term elevated IGF-1 has been epidemiologically associated with certain cancers; absolute contraindication for active or suspected malignancy.

06 · Common Stacks

Frequently stacked with growth hormone secretagogues (CJC/Ipamorelin) or short cycles alongside anabolic protocols. Not for beginners.

07 · Regulatory Status

Research use only. Not FDA-approved for performance use.

08 · References & Further Reading
R.01
IGF-1 and skeletal muscle: mechanisms of anabolism
Endocrine Reviews (2019)
↗
R.02
Long R3 IGF-1: extended half-life and mechanism
Biochemical Journal (1993)
↗
R.03
IGF-1 signaling in skeletal muscle hypertrophy
Molecular and Cellular Endocrinology (2015)
↗
09 · Frequently Asked Questions
How does IGF-1 LR3 work?+
Binds IGF-1 receptors on muscle cells and drives PI3K/Akt/mTOR signaling — the primary anabolic pathway for protein synthesis. Also stimulates satellite cell proliferation and differentiation, expanding the pool of nuclei available to muscle fibers. Partial insulin-receptor cross-reactivity means it also drives glucose uptake.
What are the reported benefits of IGF-1 LR3?+
Rapid, visible muscle hypertrophy during growth phases Dramatically reduced recovery time between sessions Improved nutrient partitioning — food goes toward muscle, not fat Increased strength alongside size gains Note: reported benefits vary and much of the evidence is preclinical.
Is IGF-1 LR3 safe?+
Advanced-user territory. Insulin-mimetic effects can cause hypoglycemia — do not use without a clear plan for food timing and glucose monitoring. Long-term elevated IGF-1 has been epidemiologically associated with certain cancers; absolute contraindication for active or suspected malignancy.
What is the regulatory status of IGF-1 LR3?+
Research use only. Not FDA-approved for performance use.
Educational content only · Reviewed July 8, 2026 by HelixHouse Research Team

This page summarizes publicly available research. Nothing here is medical advice, a prescription, or a diagnosis. Peptides described are not FDA-approved for the uses discussed unless explicitly noted. Consult a qualified physician before starting any protocol.